tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TYRA Stock Latest News

Tyra Biosciences price target raised to $36 from $30 at Oppenheimer
The FlyTyra Biosciences price target raised to $36 from $30 at Oppenheimer
20d ago
TYRA
Tyra Biosciences management to meet with Oppenheimer
PremiumThe Fly
Tyra Biosciences management to meet with Oppenheimer
26d ago
TYRA
Tyra Biosciences initiated with a Strong Buy at Raymond James
PremiumThe Fly
Tyra Biosciences initiated with a Strong Buy at Raymond James
27d ago
TYRA
Tyra Bioscience’s Promising Developments in NMIBC and Achondroplasia Drive Buy Rating
PremiumRatings
Tyra Bioscience’s Promising Developments in NMIBC and Achondroplasia Drive Buy Rating
1M ago
TYRA
Tyra Bioscience Begins Phase 2 Study for Achondroplasia
PremiumCompany Announcements
Tyra Bioscience Begins Phase 2 Study for Achondroplasia
1M ago
8K
TYRA
Tyra Biosciences says first child dosed in BEACH301 trial
PremiumThe FlyTyra Biosciences says first child dosed in BEACH301 trial
1M ago
TYRA
Tyra Bioscience: Strategic Advancements and Financial Stability Justify Buy Rating
Premium
Ratings
Tyra Bioscience: Strategic Advancements and Financial Stability Justify Buy Rating
2M ago
TYRA
Tyra Bioscience: Promising Clinical Trials and Financial Stability Justify Buy Rating
Premium
Ratings
Tyra Bioscience: Promising Clinical Trials and Financial Stability Justify Buy Rating
2M ago
TYRA
Tyra Biosciences Advances Clinical Programs with Strong Financial Backing
PremiumCompany Announcements
Tyra Biosciences Advances Clinical Programs with Strong Financial Backing
2M ago
TYRA
Tyra Biosciences reports Q2 EPS (47c), consensus (51c)
PremiumThe Fly
Tyra Biosciences reports Q2 EPS (47c), consensus (51c)
2M ago
TYRA
Tyra Biosciences announces presentation on TYRA-300 preclinical results at ENDO
PremiumThe Fly
Tyra Biosciences announces presentation on TYRA-300 preclinical results at ENDO
3M ago
TYRA
Promising Outlook for Tyra Bioscience: Buy Rating Driven by TYRA-300’s Potential in NMIBC Treatment
PremiumRatings
Promising Outlook for Tyra Bioscience: Buy Rating Driven by TYRA-300’s Potential in NMIBC Treatment
3M ago
TYRA
Tyra Bioscience Launches Phase 2 Study for TYRA-300
PremiumCompany AnnouncementsTyra Bioscience Launches Phase 2 Study for TYRA-300
3M ago
8K
TYRA
Tyra Biosciences says first patient dosed in Phase 2 study of TYRA-300
Premium
The Fly
Tyra Biosciences says first patient dosed in Phase 2 study of TYRA-300
3M ago
TYRA
Tyra Biosciences up 3% as RA Capital increases stake to 22.4%
Premium
The Fly
Tyra Biosciences up 3% as RA Capital increases stake to 22.4%
4M ago
TYRA
Tyra Bioscience Holds 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Tyra Bioscience Holds 2025 Annual Stockholders Meeting
4M ago
8K
TYRA
Tyra Biosciences management to meet with Oppenheimer
PremiumThe Fly
Tyra Biosciences management to meet with Oppenheimer
4M ago
TYRA
Tyra Biosciences assumed with an Overweight at Piper Sandler
PremiumThe Fly
Tyra Biosciences assumed with an Overweight at Piper Sandler
4M ago
TYRA
Tyra Biosciences Reports Increased R&D Investment in Q1 2025
PremiumCompany Announcements
Tyra Biosciences Reports Increased R&D Investment in Q1 2025
5M ago
TYRA
Tyra Biosciences files $500M mixed securities shelf
PremiumThe FlyTyra Biosciences files $500M mixed securities shelf
5M ago
TYRA
Tyra Biosciences reports Q1 EPS (47c), consensus (48c)
Premium
The Fly
Tyra Biosciences reports Q1 EPS (47c), consensus (48c)
5M ago
TYRA
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
Premium
The Fly
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
5M ago
IDYA
NRIX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >